Duke University
Cary, North Carolina, United States
Afreen Shariff, MD is an endocrinologist with expertise in endocrine disease in cancer patients. She is the founding Director of the Duke Endo-Oncology Program and an Associate Director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She holds a faculty appointment as an Assistant Professor of Medicine in the Division of Endocrinology, Diabetes and Metabolism at Duke University School of Medicine.
She also chairs the Oncoendocrinology Special Interest Group (SIG) with the Endocrine Society and influences global networking, clinical practice and education in the field of Onco endocrinology. At Duke, Dr. Shariff's work includes developing interdisciplinary partnerships, creating the clinical infrastructure and framework needed for AI assisted clinical decision making to improve access and coordinated care for patients with cancer therapy related toxicities. She has published in numerous peer-reviewed journals, speaks at national conferences and for industry partners. She also hosts and produces the podcast series Checkpoint NOW that emphasizes shared decision making between oncologists and subspecialists.
Disclosure information not submitted.